Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Eplerenone,Primary aldosteronism; intolerant to spironolactone,Eplerenone (Inspra),Options for investment,Community and Hospital,Cardiovascular System
